Notícias e Atividades da BlueSphere Bio

Veja o organograma con seus 11 executivos principais

Biografias mais buscadas da BlueSphere Bio

• Keir Loiacono, Chief Executive Officer and Director
• Jeanne Cunicelli, Board Member
• Alan Korman, Board Member

Criar um alerta
para seguir os movimentos de executivos da BlueSphere Bio.

BlueSphere Bio possui 2.339 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Biogen (Estados Unidos).

Popular M&A news in Biotecnologia

• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (publicado em 30 de abril de 2025)..
• Deepull acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 29 de abril de 2025).
• Biolinq acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 23 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Herriot Tabuteau - Chief Executive Officer and Director da Axsome Therapeutics
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de BlueSphere Bio

• BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial | BlueSphere Bio
• BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS | BlueSphere Bio
• BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
• BlueSphere Bio Announces IND Clearance of its First in Human Candidate and New Cell Therapy Portfolio for High-Risk Leukemia Patients | BlueSphere Bio
• BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease | BlueSphere Bio
• BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention | BlueSphere Bio
• BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference | BlueSphere Bio
• BlueSphere Bio to Present at the 25th Annual BIO CEO & Investor Conference | BlueSphere Bio
• BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer | BlueSphere Bio
• BlueSphere Bio Presents Data Demonstrating the Potential of Lead Product Candidate at 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting | BlueSphere Bio
• View more press releases Close

Redes sociais sobre BlueSphere Bio

• BlueSphere Bio na Wikipedia, Google News e Yahoo Finance
• BlueSphere Bio na LinkedIn, Twitter e YouTube